PD-1 antibody (Toripalimab)

DRUG3 trials

Sponsors

Fudan University, Sixth Affiliated Hospital, Sun Yat-sen University, Sun Yat-sen University

Conditions

Early Low Rectal CancerNasopharyngeal Cancinoma (NPC)Recurrent Rectal Cancer

Phase 2

Short-course Radiotherapy Combined With CAPOX and PD-1 Antibody Versus Long-course Chemoradiotherapy Combined With CAPOX for Early Low-lying Rectal Cancer

RecruitingNCT06462053

Fudan UniversityEarly Low Rectal Cancer

Start: 2024-04-01End: 2027-03-01Target: 134Updated: 2024-06-17

Preoperative Chemoradiotherapy and Toripalimab in Locally Recurrent Rectal Cancer

Not yet recruitingNCT06751394

Sixth Affiliated Hospital, Sun Yat-sen UniversityRecurrent Rectal Cancer

Start: 2025-01-01End: 2028-12-31Target: 44Updated: 2024-12-27

Radiotherapy Omitting Prophylactic Neck Irradiation With Neoadjuvant and Adjuvant Toripalimab in Nasopharyngeal Carcinoma

Not yet recruitingNCT07110558

Sun Yat-sen UniversityNasopharyngeal Cancinoma (NPC)

Start: 2025-08-15End: 2032-08-14Target: 59Updated: 2025-08-07